Dr. Prashanth Paramesh Santhekadur, MD

Dr. Santhekadur practices at Ascension Saint Agnes Hospital in Baltimore, Maryland, part of Ascension Health Alliance.

Dr. Santhekadur's NPI, 1780706820, was assigned on April 6, 2007. Dr. Santhekadur holds Maryland license D0066350.

Dr. Santhekadur's primary practice is Ascension Saint Agnes Hospital, at 900 Caton Avenue, Baltimore, MD 21229 in Baltimore City. The practice phone is (410) 368-6000.

Dr. Santhekadur's primary practice is Ascension Saint Agnes Hospital in Baltimore, Maryland, part of Ascension Health Alliance. Dr. Santhekadur is also affiliated with MedStar Harbor Hospital. The medical group on file is Integrated Specialists Group. Dmand AI also links Dr. Santhekadur to 2 more medical groups, 1 group practice or clinic and 1 home health agency, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Santhekadur practices, 4 sites in all. Vendor and product names are available with a free account.

Infectious disease is Dr. Santhekadur's primary specialty in the NPI Registry, under taxonomy code 207RI0200X. Dr. Santhekadur is licensed in Maryland.

CMS data shows 1,673 Medicare services from Dr. Santhekadur across 11 procedure codes in 2024, for 447 Medicare patients. Medicare paid $133,250 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 447 Medicare patients who saw Dr. Santhekadur in 2024. The largest group is 65 to 74, with 162 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 35% are also on Medicaid. Their average risk score is 3.04, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Santhekadur's median patient age at 67, with 53% women.

In 2024, Dr. Santhekadur wrote 213 Medicare Part D claims for 49 patients. 83% of them were for generic drugs. CMS names the drug for 123 of them, across 6 drugs with 11 or more claims each, at $69,746 in total drug cost. In 2023, CMS named 87 claims across 5 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 82 out of 100 for Dr. Santhekadur for performance year 2024, reported as part of a group. Dr. Santhekadur accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 104 procedures of removal of tissue by Dr. Santhekadur, more than 86% of the clinicians it reports for that procedure.

Skin biopsy: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 1 paper to Dr. Santhekadur.

CMS Open Payments shows 27 general payments to Dr. Santhekadur from 9 drug and device companies from 2016 to 2024. Food and beverage make up the largest share, 99% of the total. Gilead Sciences, Inc. paid the most, $243.